20261026 Webinar CAR-T or Autologous/Allogeneic HCT for Relapsed and Refractory DLBCL

The Education & Dissemination Committee of the WBMT is organizing a webinar to discuss evolving treatment strategies for relapsed/refractory diffuse large B‑cell lymphoma (DLBCL), highlighting the role of CAR T‑cells and HCT, including their role in the settings of broad and limited access to cellular therapies. Expert speakers will discuss current paradigms, share clinical insights and address ongoing controversies shaping patient care. Discover our webinar database on www.wbmt.org. @WBMT.org